Skip to main content
TipRanks
Go Ultimate75% OFF

Graeme Kaufman Insider Profile

4 Followers

Graeme Kaufman, Director at Paradigm Biopharmaceuticals, holds 1.89M shares in Paradigm Biopharmaceuticals (Ticker: PBIGF). Most recently, Graeme Kaufman Sold 184,216 shares of Paradigm Biopharmaceuticals on May 12, 2020 for an estimated value of $423.70K.

Graeme Kaufman's Trading History

PBIGF
Paradigm Biopharmaceuticals
May 12, 2020DirectorInformative Sell423.70K$20.79K
PBIGF
Insider Shares: 1.89M (84.10%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
May 12, 2020Informative SellAU$423.70K184,216AU$2.30-97.70%―
Dec 09, 2016Informative BuyAU$15.00K31,250AU$0.48――

You May Also Like

Graeme Kaufman insider profile FAQ

What stocks does Graeme Kaufman hold?
Graeme Kaufman holds: PBIGF stocks.
What was Graeme Kaufman’s latest transaction?
Graeme Kaufman’s latest transaction was an Informative Sell of $423.70K.
What was Graeme Kaufman's most profitable transaction?
Graeme Kaufman’s most profitable transaction was an Informative Sell of PBIGF stock on May 12, 2020. The return on the trade was -97.70%.
What is Graeme Kaufman's role in Paradigm Biopharmaceuticals?
Graeme Kaufman's role in Paradigm Biopharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.